Antiphospholipid Syndrome in Pregnancy
7
2
2
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
14.3%
1 terminated out of 7 trials
0.0%
-86.5% vs benchmark
14%
1 trials in Phase 3/4
0%
1 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (7)
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
Placental Pathology and Inflammatory Factor Analysis of OAPS
HYDROxychloroquine in Syndrome Primary AntiPhospholipid
Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?
AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study
The Value of Placental Vascularization and Placental Volume in Pregnancy in APLS